An hour after immunization peritoneal B-1 cells are activated to migrate to lymphoid organs where within 1 day they produce IgM antibodies that initiate elicitation of contact sensitivity

Journal of Immunology

Volumn 175, Issue 11, 2005, Pages 7170-7178

  Itakura, Atsuko ^a   Szczepanik, Marian ^b   Campos, Regis A ^a   Paliwal, Vipin ^a   Majewska, Monika ^b   Matsuda, Hiroshi ^c,d   Takatsu, Kiyoshi ^d   Askenase, Philip W ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BURKITT LYMPHOMA RECEPTOR 1; CHEMOKINE; GUANINE NUCLEOTIDE BINDING PROTEIN; IMMUNOGLOBULIN M ANTIBODY; PERTUSSIS TOXIN; RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; ARTICLE; B 1 CELL; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; CELLULAR IMMUNITY; CONTACT SENSITIVITY; CONTROLLED STUDY; EFFECTOR CELL; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; IMMUNIZATION; LYMPH NODE; LYMPHOCYTE MIGRATION; LYMPHOID ORGAN; MALE; MOUSE; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; SERUM; SIGNAL TRANSDUCTION; SPLEEN;

EID: 27744472624     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.11.7170     Document Type: Article

References (34)

1. Askenase, P. W. 2003. Delayed-type hypersensitivity and cellular immunity: effector/regulator molecules and mechanisms. In Middleton's Allergy: Principles and Practice. N. F. Adkinson, Jr., S. T. Holgate, B. S. Bochner, W. W. Busse, J. W. Yunginger, and E. E. R. Simmons, eds. Mosby, Philadelphia, p. 425.
2. Kops, S. K., H. Van Loveren, R. W. Rosenstein, W. Ptak, and P. W. Askenase. 1984. Mast cell activation and vascular alterations in immediate hypersensitivity-like reactions induced by a T cell-derived antigen-binding factor. Lab. Invest. 50: 421-434.
3. McHale, J. F., O. A. Harari, D. Marshall, and D. O. Haskard. 1999. Vascular endothelial cell expression of TCAM-1 and VCAM-1 at the onset of eliciting contact hypersensitivity in mice: evidence for a dominant role of TNF-α. J. Immunol. 162: 1648-1655.
4. Tsuji, R. F., M. Szczepanik, I. Kawikova, V. Paliwal, R. A. Campos, A. Itakura, M. Akahira-Azuma, N. Baumgarth, L. A. Herzenberg, and P. W. Askenase. 2002. B cell-dependent T cell responses: IgM antibodies are required to elicit contact sensitivity. J. Exp. Med. 196: 1277-1290.
5. Tsuji, R. F., M. Kikuchi, and P. W. Askenase. 1996. Possible involvement of C5/C5a in the efferent and elicitation phases of contact sensitivity. J. Immunol. 156: 4444-4450.
6. Tsuji, R. F., G. P. Geba, Y. Wang, K. Kawamoto, L. A. Matis, and P. W. Askenase. 1997. Required early complement activation in contact sensitivity with generation of local C5-dependent chemotactic activity, and late T cell interferon γ: a possible initiating role of B cells. J. Exp. Med. 186: 1015-1026.
7. Tsuji, R. F., I. Kawikova, R. Ramabhadran, M. Akahira-Azuma, D. Taub, T. E. Hugh, C. Gerard, and P. W. Askenase. 2000. Early local generation of C5a initiates the elicitation of contact sensitivity by leading to early T cell recruitment. J. Immunol. 165: 1588-1598.
8. Geba, G. P., W. Ptak, G. M. Anderson, V. Paliwal, R. E. Ratzlaff, J. Levin, and P. W. Askenase. 1996. Delayed-type hypersensitivity in mast cell-deficient mice: dependence on platelets for expression of-contact sensitivity. J. Immunol. 157: 557-565.
9. Van Loveren, H., and P. W. Askenase. 1984. Delayed-type hypersensitivity is mediated by a sequence of two different T cell activities. J. Immunol. 133: 2397-2401.
10. Macpherson, A. J., A. Lamarre, K. McCoy, G. R. Harriman, B. Odermatt, G. Dougan, H. Hengartner, and R. M. Zinkemagel. 2001. IgA production without μ or δ chain expression in developing B cells. Nat. Immunol. 2: 625-631.
11. Hardy, R. R., and K. Hayakawa. 1994. CD5 B cells, a fetal B cell lineage. Adv. Immunol. 55: 297-339.
12. Kaslow, H. R., and D. L. Burns. 1992. Pertussis toxin and target eukaryotic cells: binding, entry, and activation. FASEB J. 6: 2684-2690.
13. Förster, R., A. E. Mattis, E. Kremmer, E. Wolf, G. Brem, and M. Lipp. 1996. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87: 1037-1047.
14. Askenase, P. W., and G. L. Asherson. 1972. Contact sensitivity to oxazolone in the mouse. VIII. Demonstration of several classes of antibody in the sera of contact sensitized and unimmunized mice by a simplified antiglobulin assay. Immunology 23: 289-298.
15. + dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC. J. Exp. Med. 193: 1393-1402.
16. Herzenberg, L. A., A. M. Stall, P. A. Lalor, C. Sidman, W. A. Moore, and D. R. Parks. 1986. The Ly-1 B cell lineage. Immunol. Rev. 93: 81-102.
17. Karras, J. G., Z. Wang, L. Huo, R. G. Howard, D. A. Frank, and T. L. Rothstein. 1997. Signal transducer and activator of transcription-3 (STAT3) is constitutively activated in normal, self-renewing B-1 cells but only inducibly expressed in conventional B lymphocytes. J. Exp. Med. 185: 1035-1042.
18. + B-1 cells have signaling properties similar to tolerant B cells. J. Biol. Chem. 277: 30707-30715.
19. Kawahara, T., H. Ohdan, G. Zhao, Y.-G. Yang, and M. Sykes. 2003. Peritoneal cavity B cells are precursors of splenic IgM natural antibody-producing cells. J. Immunol. 171: 5406-5414.
20. Ian, C. M., C. Vinuesa, and T. S. Migone. 2002. Dendritic cells, BAFF, and APRIL: innate players in adaptive antibody responses. Immunity 17: 235-238.
21. Bikah, G., J. Carey, J. R. Ciallella, A. Tarakhovsky, and S. Bondada. 1996. CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells. Science 274: 1906-1909.
22. Morris, D. L., and T. L. Rothstein, 1993. Abnormal transcription factor induction through the surface immunoglobulin M receptor of B-1 lymphocytes. J. Exp. Med. 177: 857-861.
23. Sen, G., H.-J. Wu, G. Bikah, C. Venkataraman, D. A. Robertson, E. C. Snow, and S. Bondada. 2002. Defective CD19-dependent signaling in B-1a and B-1b B lymphocyte subpopulations. Mol. Immunol. 39: 57-68.
24. Campos, R. A., M. Szczepanik, A. Itakura, M. Akahira-Azuma, S. Sidobre, M. Kronenberg, and P. W. Askenase. 2003. Cutaneous immunization rapidly activates liver invariant Vα14 NKT cells stimulating B-1 B cells to initiate T cell recruitment for elicitation of contact sensitivity. J. Exp. Med. 198: 1785-1796.
25. Pior, J., T. Vogl, C. Sorg, and E. MacHer. 1999. Free hapten molecules are dispersed by way of the bloodstream during contact sensitization to fluorescein isothiocyanate. J. Invest. Dermatol. 113: 888-893.
26. Mori, M., S. C. Morris, T. Orekhova, M. Marinaro, E. Giannini, and F. D. Finkelman. 2000. IL-4 promotes the migration of circulating B cells to the spleen and increases splenic B cell survival. J. Immunol. 164: 5704-5712.
27. Szczepanik, M., M. Akahira-Azuma, K. Bryniarski, R. F. Tsuji, I. Kawikova, W. Ptak, R. A. Campos, and P. W. Askenase. 2003. B-1 B cells mediate required early T cell recruitment to elicit protein-induced delayed-type hypersensitivity. J. Immunol. 171: 6225-6235.
28. Svensson, L., J. Jirholt, R. Holmdahl, and L. Jansson. 1998. B cell-deficient mice do not develop type 11 collagen-induced arthritis (CIA). Clin. Exp. Immunol. 111: 521-526.
29. Grant, E. P., D. Picarella, T. Burwell, T. Delaney, A. Croci, N. Avitahl, A. A. Humbles, J. C. Gutierrez-Ramos, M. Briskin, C. Gerard, et al. 2002. Essential role for the C5a receptor in regulating the effector phase of synovial infiltration and joint destruction in experimental arthritis. J. Exp. Med. 196: 1461-1471.
30. Kakizoe, E., S. H. Li, Y. Kobayashi, Y. Nishikori, S. Dekio, and H. Okunishi. 1999. Increases in mast cells and chymase in fibroproliferative paws of collagen-induced arthritic mice. Inflamm. Res. 48: 318-324.
31. Lyons, J. A., M. J. Ramsbottom, and A. H. Cross. 2002. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein. Eur. J. Immunol. 32: 1905-1913.
32. Secor, V. H., W. E. Secor, C. A. Gutekunst, and M. A. Brown. 2000. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J. Exp. Med. 191: 813-822.
33. Nataf, S., S. L. Carroll, R. A. Wetsel, A. J. Szalai, and S. R. Barnum. 2000. Attenuation of experimental autoimmune demyelination in complement-deficient mice. J. Immunol. 165: 5867-5873.
34. Ptak, W., G. P. Geba, and P. W. Askenase. 1991. Initiation of delayed-type hypersensitivity by low doses of monoclonal IgE antibody: mediation by serotonin and inhibition by histamine. J. Immunol. 146: 3929-3936.